Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review
Top Cited Papers
- 18 February 2014
- journal article
- review article
- Published by Elsevier
- Vol. 95 (1) , 133-138
- https://doi.org/10.1016/j.ygyno.2004.06.045
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Fertility‐preserving treatment in young patients with endometrial adenocarcinomaCancer, 2002
- Endometrial Carcinoma Remaining after Term Pregnancy Following Conservative Treatment with Medroxyprogesterone AcetateGynecologic Oncology, 2000
- Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancerPublished by Wolters Kluwer Health ,2000
- Endometrial cancer in premenopausal women 45 years and youngerPublished by Wolters Kluwer Health ,2000
- Conservative management of endometrial carcinoma with prolonged preservation of the uterus in a young patientInternational Journal of Gynecologic Cancer, 1997
- Progestin alone as primary treatment of endometrial carcinoma in premenopausal womenCancer, 1997
- Conservative Treatment of Endometrial Cancer Permitting Subsequent Triplet PregnancyGynecologic Oncology, 1995
- PRIMARY TREATMENT OF ENDOMETRIAL CANCER WITH PROGESTAGEN ALONEThe Lancet, 1985
- The treatment of advanced endometrial cancer with hydroxyprogesterone caproateGynecologic Oncology, 1974
- CLINICAL AND HISTOPATHOLOGIC EVALUATION OF THE EFFECT OF 17-ALPHA-HYDROXYPROGESTERONE-17-N-CAPROATE ON ENDOMETRIAL CARCINOMAObstetrical & Gynecological Survey, 1962